✦ LIBER ✦

Investigating harms in clinical trials – no easy task

✍ Scribed by M. J. Bolland; A. Grey; G. D. Gamble; I. R. Reid

Book ID: 111309470
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 95 KB
Volume: 64
Category: Article
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2010.02539.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integration of breast MRI in clinical tr

Integration of breast MRI in clinical trials

✍ Steven E. Harms 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Abstract Clinical trials are the mechanism for implementing new treatment methods into clinical practice. A number of organizations have been developed to facilitate the initiation, implementation, and data analysis for clinical trials. Imaging is important for patient selection and establishmen

No more boring science, no more waste in

No more boring science, no more waste in clinical trials

✍ Jeffrey Laurence 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Task force 2: Investigator participation

Task force 2: Investigator participation in clinical research

✍ Robert M. Califf; Steven E. Nissen; Anthony N. DeMaria; Erik Magnus Ohman; Bertr 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Failure to report harms and adverse even

Failure to report harms and adverse events in clinical trials: Why does the problem continue?

✍ Donald R. Miller MD 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 French ⚖ 222 KB

The investigator-sponsored IND in clinic

The investigator-sponsored IND in clinical trials

✍ Clair Haakenson; Carol L. Fye; Mike R. Sather; Dennis J. Toussaint 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 614 KB

Guidelines for Clinical Investigator Inv

Guidelines for Clinical Investigator Involvement in Industry-sponsored Clinical Trials

✍ Edward A. Panacek; Roger J. Lewis 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB